# ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant Patients

> **NCT07516314** · NA · NOT_YET_RECRUITING · sponsor: **Anthony Sung, MD** · enrollment: 476 (estimated)

## Conditions studied

- Stem Cell Transplant Patients

## Interventions

- **BEHAVIORAL:** ACTivate sessions

## Key facts

- **NCT ID:** NCT07516314
- **Lead sponsor:** Anthony Sung, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2030-01
- **Final completion:** 2031-04
- **Target enrollment:** 476 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07516314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07516314, "ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07516314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*